Cellular oncology (Dordrecht, Netherlands)
Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Ioannis Pozios, Nina N Seel, Nina A Hering, Lisa Hartmann, Verena Liu, Peter Camaj, Mario H Müller, Lucas D Lee, Christiane J Bruns, Martin E Kreis, Hendrik Seeliger
Published: 202510.1007/s13402-025-01128-8
No abstract available for this study.